https://www.avient.com/sites/default/files/2024-01/ColorMatrix AAnchor Brochure_A4.pdf
Recycle
Loop
AAnchor
Mg/kg
Anthranilamide
Mg/kg
Virgin
https://www.avient.com/sites/default/files/2021-10/remafin-ep-white-masterbatches-for-pharma-application-bulletin_0.pdf
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/sites/default/files/2022-09/Cesa Aversive Product Bulletin.pdf
KEY CHARACTERISTICS
• Compliant with BPR EU No. 528/2012 PT19
requirements
• Designed for incorporation into cable jackets
exposed to rats and termites attack
• Efficacy at low dosing 2–4%
• “Low concern” and long lasting active substance
• Compatible with most polymers
TARGET MARKET AND APPLICATIONS
Appropriate for all applications where cables can be
exposed to rats and termites.
https://www.avient.com/sites/default/files/2022-04/MEVOPUR LQ for Silicone Elastomers.pdf
Avient products have not been designed for nor are they promoted or intended for use in:
(a) medical devices categorized by either the United States Food and Drug Administration (FDA) or the International Standards Organization (ISO) as an “implant” device; or “Permanent” as defined under
US Pharmacopoeia (USP) or ISO standards; or
(b) active implantable medical devices as defined in EU Directive 90/385/EEC as amended; or
(c) medical devices for “Long Term” use as defined in EU Directive 93/42/EEC as amended.
https://www.avient.com/sites/default/files/2020-10/excelite-im-product-bulletin-americas-1.pdf
PP, PE,
PS, PVC No Good
Foam PP
Better, larger cells with lower cell
density in standard IM processes;
suitable for cell nucleation in
structural foam processing
PP, PE,
PS, PVC Yes Better
FA-110
Best cell structure with higher cell
density; provides better structural
integrity and lower density in
standard IM processes
PP, PE,
PS, PVC Yes Best
KEY CHARACTERISTICS
Excelite IM formulations provide
injection molders with:
• Material density and weight reduction
• High concentration of active CFA
• Improved distribution of CFA into
polymer matrix
• High cell density with tight cell structure
• Control over consistency and accuracy
• Reduced sink marks
• Ability to improve flow of material
• Cycle time reduction
• Improved dimensional stability
• Improved thermal insulation
EXCELITE IM – PRODUCT FORMULATIONS
www.avient.com
Copyright © 2020, Avient Corporation.
https://www.avient.com/sites/default/files/2024-10/Terms%26Conditions - Brazil English %26 Portuguese.pdf
Seller reserves the right to change these
Terms and Conditions at any time, through
a written communication to Buyer, without
any need for obtaining any prior acceptance
by or approval from Buyer.
1.2.
Buyer may
assign/transfer rights and/or delegate
duties/obligations hereunder only with the
prior written consent of Seller, not
unreasonably withheld.
Seller may assign
this contract and/or rights and delegate
obligations under this contract without the
consent of Buyer.
13.
https://www.avient.com/sites/default/files/resources/Terms%2520and%2520Conditions%2520of%2520Sale%2520for%2520Hungary.pdf
Seller reserves a right to
discontinue any Product sold hereunder at any time,
unless Buyer and Seller are bound by a pre-existing
master agreement which would require Seller to notify
Buyer of such discontinuance.
5.
Amennyiben másképpen nem szerepel,
- 4 -
PAI-376902v1
arising out of unloading, discharge, storage, handling
and use of the Product, or arising out of compliance or
non-compliance with applicable laws and regulations
governing or controlling such activity.
ASSIGNMENT/DELEGATION
Buyer may assign/transfer rights and/or delegate
duties/obligations hereunder only with the prior
written consent of Seller.
16.
https://www.avient.com/sites/default/files/2020-10/colormatrix-reprize-for-rpet-brochure.pdf
PROCESSING AND HANDLING
ColorMatrix rePrize is active “as supplied”.
https://www.avient.com/sites/default/files/2020-08/colormatrix-optica-toner-dispersions-tech-bulletin-a4.pdf
ColorMatrix strongly recommends diluting the 15%
dispersion with MEG at ambient temperature to a
suggested active concentration of approximately
5% or thereabouts.
https://www.avient.com/sites/default/files/2023-10/Nonwoven Colorants and Additives Brochure_A4.pdf
The active ingredient is
compliant with FDA/EU regulations*.